Pathstone Family Office, LLC Acumen Pharmaceuticals, Inc. Transaction History
Pathstone Family Office, LLC
- $15.6 Billion
- Q3 2023
A detailed history of Pathstone Family Office, LLC transactions in Acumen Pharmaceuticals, Inc. stock. As of the latest transaction made, Pathstone Family Office, LLC holds 478,790 shares of ABOS stock, worth $1.13 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
478,790
Previous 467,060
2.51%
Holding current value
$1.13 Million
Previous $2.25 Million
11.58%
% of portfolio
0.01%
Previous 0.03%
Shares
8 transactions
Others Institutions Holding ABOS
# of Institutions
84Shares Held
26.8MCall Options Held
319KPut Options Held
86.3K-
Sands Capital Ventures, LLC Arlington, VA3.42MShares$8.1 Million4.42% of portfolio
-
Franklin Resources Inc San Mateo, CA3.4MShares$8.05 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.63MShares$6.23 Million0.0% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD2.3MShares$5.45 Million0.24% of portfolio
-
Laurion Capital Management LP New York, NY1.9MShares$4.49 Million0.07% of portfolio
About Acumen Pharmaceuticals, Inc.
- Ticker ABOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,503,100
- Market Cap $96M
- Description
- Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Ph...